We are live on
!
Find out more
AICPI
ABG Innovation Capital Partners III Portfolio holdings
AUM
$64.5K
1-Year Est. Return
1.01%
This Fund
S&P 500
This Quarter
Est. Return
-3.69%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
–
AUM
$860K
AUM Growth
+$27.7K
(+3.3%)
Cap. Flow
+$69.5K
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Castle Biosciences
CSTL
|
+$69.5K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
FFVM
SNN
AC
MI
FFVM
FFVM
NA
IVSFI
ABG Innovation Capital Partners III's Q2 2024 Portfolio in Review
As of Q2 2024, ABG Innovation Capital Partners III held 3 positions worth $860K, up 3.3% from $832K the previous quarter. Its ten largest holdings account for 100% of the portfolio.
ABG Innovation Capital Partners III deployed $69.5K of net new capital in Q2 2024, adding to 1 existing holding.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- ABG Innovation Capital Partners III added most to Castle Biosciences in Q2 2024, an estimated $69.5K increase.
- ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $860K portfolio in Q2 2024.
- ABG Innovation Capital Partners III opened 0 new positions and closed 0 in Q2 2024.
- ABG Innovation Capital Partners III's portfolio value rose 3.3% quarter-over-quarter to $860K.
Based on ABG Innovation Capital Partners III's 13F filing for Q2 2024, filed 14 Aug 2024.